US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ceribell

14.85

+0.35502.45%

Post-market: 14.850.00000.00%19:32 EDT

Volume:621.58K

Turnover:9.28M

Market Cap:532.47M

PE:-4.39

High:15.18

Open:14.38

Low:14.30

Close:14.49

Loading ...

Overview Company News Filings

CeriBell Q4 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $18.53M Beat $17.55M Estimate

Ceribell reports Q4 EPS (40c), consensus (31c)

Ceribell sees FY25 revenue $81M-$85M, consensus $81.32M

Ceribell Inc: Qtrly Loss per Share $0.40

THOMSON REUTERS

Ceribell Inc - Reports Q4 2024 Revenue of $18.5 Million

THOMSON REUTERS

Ceribell Inc Q4 REV View $17.6 Mln -- Lseg Ibes Data

THOMSON REUTERS

CeriBell Inc expected to post a loss of 32 cents a share - Earnings Preview

Calendar of U.S. Earnings Expected in the Week Ahead

Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference

Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

Beta Bionics targets up to $616 mln valuation in US IPO

J.P. Morgan Keeps Their Buy Rating on Ceribell, Inc. (CBLL)

Ceribell price target raised to $36 from $31 at TD Cowen

Ceribell Inc : TD Cowen Raises Target Price to $36 From $31

THOMSON REUTERS

Ceribell, Inc. Set for Growth: Buy Rating Affirmed with Raised Price Target to $36

Ceribell’s Strategic Growth Potential: A Buy Rating Backed by Strong Financials and Competitive Edge

Ceribell appoints Rodenbush as CPO, Price as SVP of Marketing

Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

THOMSON REUTERS

Press Release: Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing

CeriBell Is Maintained at Buy by Canaccord Genuity

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CBLL/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CBLL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","market":"US","secType":"STK","nameCN":"Ceribell","latestPrice":14.845,"timestamp":1744920000000,"preClose":14.49,"halted":0,"volume":621579,"hourTrading":{"tag":"盘后","latestPrice":14.845,"preClose":14.845,"latestTime":"19:32 EDT","volume":6609,"amount":98110.6,"timestamp":1744932730916},"delay":0,"floatShares":21912409,"shares":35868339,"eps":-3.385363,"marketStatus":"Closed Good Friday","change":0.355,"latestTime":"04-17 16:00:00 EDT","open":14.38,"high":15.18,"low":14.3,"amount":9280758.75426,"amplitude":0.060732,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.385363,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1728619200000,"exchange":"NASDAQ","adjPreClose":14.49,"preHourTrading":{"tag":"盘前","latestPrice":15.19,"preClose":14.49,"latestTime":"08:23 EDT","volume":66,"amount":993.39999,"timestamp":1744892622477},"postHourTrading":{"tag":"盘后","latestPrice":14.845,"preClose":14.845,"latestTime":"19:32 EDT","volume":6609,"amount":98110.6,"timestamp":1744932730916},"volumeRatio":0.6620269234660353,"impliedVol":0.9753,"impliedVolPercentile":0.8649},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBLL\",,,,,undefined,":{"symbol":"CBLL","floatShares":21912409,"roa":"-17.46%","roe":"-35.75%","lyrEps":-3.385363,"volumeRatio":0.6620269234660353,"shares":35868339,"dividePrice":0,"high":15.18,"amplitude":0.060732,"preClose":14.49,"low":14.3,"week52Low":10.01,"pbRate":"2.79","psRate":"8.14","week52High":32.7489,"institutionHeld":0,"latestPrice":14.845,"eps":-3.385363,"divideRate":0,"volume":621579,"delay":0,"ttmEps":-3.385363,"open":14.38,"prevYearClose":25.88,"prevWeekClose":15,"prevMonthClose":19.21,"prevQuarterClose":19.21,"fiveDayClose":11.15,"twentyDayClose":20.27,"sixtyDayClose":23.24},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBLL\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514447880","title":"CeriBell Q4 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $18.53M Beat $17.55M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2514447880","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514447880?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:32","pubTimestamp":1740519163,"startTime":"0","endTime":"0","summary":"CeriBell (NASDAQ:CBLL) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.32) by 25 percent. This is a 73.86 percent increase over losses of $(1.53) per share from the same","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43958077/ceribell-q4-gaap-eps-0-40-misses-0-32-estimate-sales-18-53m-beat-17-55m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"CeriBell Q4 GAAP EPS $(0.40) Misses $(0.32) Estimate, Sales $18.53M Beat $17.55M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":1},{"id":"2514044187","title":"Ceribell reports Q4 EPS (40c), consensus (31c)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514044187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514044187?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:26","pubTimestamp":1740518781,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $18.53M, consensus $17.55M. “2024 was a transformative year for Ceribell (CBLL), as we advanced our mission to become the standa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-reports-q4-eps-40c-consensus-31c?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-reports-q4-eps-40c-consensus-31c?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2514446410","title":"Ceribell sees FY25 revenue $81M-$85M, consensus $81.32M","url":"https://stock-news.laohu8.com/highlight/detail?id=2514446410","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514446410?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:25","pubTimestamp":1740518754,"startTime":"0","endTime":"0","summary":"The company said, “Ceribell (CBLL) expects revenue for the full year 2025 to be in the range of $81 million to $85 million, representing growth of ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-sees-fy25-revenue-81m-85m-consensus-81-32m?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-sees-fy25-revenue-81m-85m-consensus-81-32m?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2514061041","title":"Ceribell Inc: Qtrly Loss per Share $0.40","url":"https://stock-news.laohu8.com/highlight/detail?id=2514061041","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514061041?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:19","pubTimestamp":1740518390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG12Y:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2514041219","title":"Ceribell Inc - Reports Q4 2024 Revenue of $18.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041219","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514041219?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:19","pubTimestamp":1740518390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG12Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2514041096","title":"Ceribell Inc  Q4 REV View $17.6 Mln -- Lseg Ibes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2514041096","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514041096?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:19","pubTimestamp":1740518390,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nFWN3PG12Y:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2513483722","title":"CeriBell Inc  expected to post a loss of 32 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2513483722","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513483722?lang=en_us&edition=fundamental","pubTime":"2025-02-22 05:50","pubTimestamp":1740174621,"startTime":"0","endTime":"0","summary":"CeriBell Inc  expected to post a loss of32cents a share - Earnings Preview CeriBell Inc CBLL.OQ CBLL.O is expected to report resultson February 25 for the period ending December 31 2024The Sunnyvale C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL5N3PC29U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0},{"id":"2513265182","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2513265182","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513265182?lang=en_us&edition=fundamental","pubTime":"2025-02-21 19:00","pubTimestamp":1740135600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Oil States Intl Inc.                              4Q       .06    7:00 AM. ·Sunstone Htl Invstrs                              4Q      (.03)   7:30 AM. ·Clean Energy Fuels                               4Q       .00    4:05 PM. ·Clear Channel Outdr                               4Q       .01    7:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTST","ATMU","KSPI","CWH","BWIN","AWI","KWR","AGM.A","AROC","AXGN","DKL","AHCO","ZM","VVX","BWXT","BGS","HLIO","ARQT","DK","CHRD","CLF","OPAD","CCCS","EVER","BMO","CPNG","BOOM","CWEN.A","CAVA","VNOM","NXE","OMAB","CGBD","AZUL","CLNE","SIBN","HLX","GFL","O","SAM","DAWN","HVT","VCYT","AGM","APLE","BOW","OKE","PLOW","GSHD","CBLL"],"gpt_icon":0},{"id":"2512192134","title":"Ceribell to Participate in the 45th Annual TD Cowen Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2512192134","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512192134?lang=en_us&edition=fundamental","pubTime":"2025-02-19 05:05","pubTimestamp":1739912700,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Feb.  18, 2025  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/18/3028297/0/en/Ceribell-to-Participate-in-the-45th-Annual-TD-Cowen-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4137","CBLL","COWN","BK4566","TD","BK4207","BK4585","HCSG","BK4082","BK4127"],"gpt_icon":0},{"id":"2510357851","title":"Ceribell to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2510357851","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510357851?lang=en_us&edition=fundamental","pubTime":"2025-02-12 05:05","pubTimestamp":1739307900,"startTime":"0","endTime":"0","summary":"SUNNYVALE, Calif., Feb.  11, 2025  (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with se","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/11/3024597/0/en/Ceribell-to-Report-Fourth-Quarter-and-Full-Year-2024-Financial-Results-on-February-25-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2505455743","title":"Beta Bionics targets up to $616 mln valuation in US IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2505455743","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505455743?lang=en_us&edition=fundamental","pubTime":"2025-01-22 19:48","pubTimestamp":1737546489,"startTime":"0","endTime":"0","summary":"UPDATE 1-Beta Bionics targets up to $616 mln valuation in US IPOAdds details throughout","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250122:nL3N3OI0UV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","LU0256863811.USD","IE00B7SZLL34.SGD","LU1883839398.USD","LU1718418525.SGD","IE00BBT3K403.USD","SIVBQ","LU0256863902.USD","LU0208291251.USD","IE00B19Z3581.USD","LU0130103400.USD","LU0980610538.SGD","LU1880398554.USD","IE00BZ1G4Q59.USD","LU0971096721.USD","LU1880398471.USD","LU2129689514.USD","LU2129689605.HKD","LU0320765489.SGD","BK4534","PIPR","LU0321505439.SGD","LU1201861165.SGD","LU0234572021.USD","LU0306807586.USD","LU1280957306.USD","LU1668664300.SGD","LU1201861249.SGD","LU1267930227.SGD","LU0640476718.USD","BK4553","BK4504","BK4559","LU1363072403.SGD","IE00B19Z3B42.SGD","LU1894683264.USD","LU0310800965.SGD","LU0149725797.USD","LU0321505868.SGD","CBLL","LU1162221912.USD","BAC","LU2133065610.SGD","LU0130518102.USD","LU1366192091.USD","LU0683600562.USD","BK4585","LU0787776722.HKD","LU0128525689.USD","SF"],"gpt_icon":1},{"id":"2503953098","title":"J.P. Morgan Keeps Their Buy Rating on Ceribell, Inc. (CBLL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503953098","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503953098?lang=en_us&edition=fundamental","pubTime":"2025-01-14 03:57","pubTimestamp":1736798234,"startTime":"0","endTime":"0","summary":"In a report released today, Robbie Marcus from J.P. Morgan maintained a Buy rating on Ceribell, Inc. (CBLL – Research Report). The company’s shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-buy-rating-on-ceribell-inc-cbll?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-keeps-their-buy-rating-on-ceribell-inc-cbll?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2490727355","title":"Ceribell price target raised to $36 from $31 at TD Cowen","url":"https://stock-news.laohu8.com/highlight/detail?id=2490727355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490727355?lang=en_us&edition=fundamental","pubTime":"2024-12-09 21:31","pubTimestamp":1733751116,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Joshua Jennings raised the firm’s price target on Ceribell (CBLL) to $36 from $31 and keeps a Buy rating on the shares. The firm s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-price-target-raised-to-36-from-31-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-price-target-raised-to-36-from-31-at-td-cowen?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TD","COWN","CBLL"],"gpt_icon":0},{"id":"2490194007","title":"Ceribell Inc : TD Cowen Raises Target Price to $36 From $31","url":"https://stock-news.laohu8.com/highlight/detail?id=2490194007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490194007?lang=en_us&edition=fundamental","pubTime":"2024-12-09 15:07","pubTimestamp":1733728028,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nFWN3NA0BW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","CBLL"],"gpt_icon":0},{"id":"2490796497","title":"Ceribell, Inc. Set for Growth: Buy Rating Affirmed with Raised Price Target to $36","url":"https://stock-news.laohu8.com/highlight/detail?id=2490796497","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490796497?lang=en_us&edition=fundamental","pubTime":"2024-12-09 11:15","pubTimestamp":1733714112,"startTime":"0","endTime":"0","summary":"Analyst Josh Jennings of TD Cowen maintained a Buy rating on Ceribell, Inc. (CBLL – Research Report), boosting the price target to $36.00. Josh Jen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ceribell-inc-set-for-growth-buy-rating-affirmed-with-raised-price-target-to-36?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ceribell-inc-set-for-growth-buy-rating-affirmed-with-raised-price-target-to-36?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2485251847","title":"Ceribell’s Strategic Growth Potential: A Buy Rating Backed by Strong Financials and Competitive Edge","url":"https://stock-news.laohu8.com/highlight/detail?id=2485251847","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485251847?lang=en_us&edition=fundamental","pubTime":"2024-11-22 20:00","pubTimestamp":1732276809,"startTime":"0","endTime":"0","summary":"In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Ceribell, Inc. (CBLL – Research Report), with a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ceribells-strategic-growth-potential-a-buy-rating-backed-by-strong-financials-and-competitive-edge?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ceribells-strategic-growth-potential-a-buy-rating-backed-by-strong-financials-and-competitive-edge?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL"],"gpt_icon":0},{"id":"2484949371","title":"Ceribell appoints Rodenbush as CPO, Price as SVP of Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2484949371","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484949371?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:10","pubTimestamp":1732021834,"startTime":"0","endTime":"0","summary":"CeriBell (CBLL) announced the appointments of Kristie Rodenbush as Chief People Officer, Rodenbush,, and Brian Price as Senior Vice President of Ma...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ceribell-appoints-rodenbush-as-cpo-price-as-svp-of-marketing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ceribell-appoints-rodenbush-as-cpo-price-as-svp-of-marketing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2484128946","title":"Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2484128946","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484128946?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:00","pubTimestamp":1732021203,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nTUA82WZRZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2484461569","title":"Press Release: Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2484461569","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484461569?lang=en_us&edition=fundamental","pubTime":"2024-11-19 21:00","pubTimestamp":1732021200,"startTime":"0","endTime":"0","summary":"Ceribell Appoints Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing. --Ms. Rodenbush to lead hiring and talent development initiatives--. --Mr. Price to focus on market development and penetration--. SUNNYVALE, Calif., Nov. 19, 2024  -- CeriBell, Inc. , a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions , today announced the appointments of Kristie Rodenbush as Chief People Officer and Brian Price as Senior Vice President of Marketing to its leadership team.Ms. Rodenbush will oversee Ceribell's People & Culture team. She has more than 25 years of human resources and talent management experience which spans various industries and includes roles at companies ranging from startups to publicly traded, international organizations. Most recently, she served as Chief People Officer of Meltwater, where she led human resources functions for more than 2,400 employees loca","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL","BK4082"],"gpt_icon":0},{"id":"2483888044","title":"CeriBell Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2483888044","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483888044?lang=en_us&edition=fundamental","pubTime":"2024-11-13 21:44","pubTimestamp":1731505440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CBLL/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 13, 2024 08:44 ET (13:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBLL"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":72,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBLL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-25","symbol":"CBLL","fiscalQuarterEnding":"2024/12","expectedEps":-0.32,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.4},{"market":"US","date":"2024-11-12","symbol":"CBLL","fiscalQuarterEnding":"2024/09","expectedEps":-0.82,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-1.85}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBLL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBLL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":6,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBLL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBLL","date":"2025-04-17","current":-12.847169,"percent":0.992188,"low":-31.439367,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"high":-9.885848,"avg":-23.337204,"sd":4.716425,"marketCap":519732232},"quantilePoints":[{"date":"2024-10-11","current":-17.636997,"twenty":-17.222009,"median":-16.599526,"eighty":-15.977044,"marketCap":578317118},{"date":"2024-10-18","current":-27.492965,"twenty":-27.233597,"median":-26.455495,"eighty":-19.29695,"marketCap":901494331},{"date":"2024-10-25","current":-28.702676,"twenty":-28.6853,"median":-27.456654,"eighty":-26.040507,"marketCap":941160750},{"date":"2024-10-31","current":-28.246561,"twenty":-28.615797,"median":-28.219411,"eighty":-26.455495,"marketCap":926204733},{"date":"2024-11-08","current":-31.439367,"twenty":-28.963313,"median":-28.463759,"eighty":-26.486619,"marketCap":1030896848},{"date":"2024-11-15","current":-27.13588,"twenty":-29.27825,"median":-28.458329,"eighty":-27.13588,"marketCap":981043460},{"date":"2024-11-22","current":-25.000572,"twenty":-28.963313,"median":-28.246561,"eighty":-25.93676,"marketCap":903845676},{"date":"2024-11-29","current":-28.528199,"twenty":-28.754803,"median":-28.246561,"eighty":-26.043953,"marketCap":1031379984},{"date":"2024-12-06","current":-28.022837,"twenty":-28.754803,"median":-28.33145,"eighty":-26.11912,"marketCap":1013109620},{"date":"2024-12-13","current":-28.934471,"twenty":-29.290749,"median":-28.463759,"eighty":-26.390638,"marketCap":1046067924},{"date":"2024-12-20","current":-26.486932,"twenty":-29.217263,"median":-28.434619,"eighty":-26.480394,"marketCap":957582042},{"date":"2024-12-27","current":-26.239205,"twenty":-29.058794,"median":-28.293244,"eighty":-26.474169,"marketCap":948625981},{"date":"2025-01-03","current":-25.624843,"twenty":-28.959703,"median":-28.107549,"eighty":-26.162518,"marketCap":926414949},{"date":"2025-01-10","current":-22.810668,"twenty":-28.950325,"median":-27.629083,"eighty":-25.703081,"marketCap":824674096},{"date":"2025-01-17","current":-19.966767,"twenty":-28.888112,"median":-27.428293,"eighty":-25.067954,"marketCap":721858516},{"date":"2025-01-24","current":-22.860214,"twenty":-28.702676,"median":-27.180566,"eighty":-24.06912,"marketCap":826465309},{"date":"2025-01-31","current":-23.583576,"twenty":-28.691816,"median":-26.734658,"eighty":-23.038577,"marketCap":852617007},{"date":"2025-02-07","current":-22.404397,"twenty":-28.676835,"median":-26.675204,"eighty":-22.810668,"marketCap":809986156},{"date":"2025-02-14","current":-21.700853,"twenty":-28.676835,"median":-26.471057,"eighty":-22.741305,"marketCap":784550943},{"date":"2025-02-21","current":-22.89985,"twenty":-28.628005,"median":-26.224342,"eighty":-22.412324,"marketCap":827898278},{"date":"2025-02-28","current":-21.066166,"twenty":-28.554982,"median":-26.070751,"eighty":-22.392506,"marketCap":852231734},{"date":"2025-03-07","current":-19.700766,"twenty":-28.530515,"median":-25.634752,"eighty":-21.924596,"marketCap":796994492},{"date":"2025-03-14","current":-18.973735,"twenty":-28.528199,"median":-25.33748,"eighty":-21.562126,"marketCap":767582454},{"date":"2025-03-21","current":-17.971851,"twenty":-28.50271,"median":-25.099663,"eighty":-21.066166,"marketCap":727051231},{"date":"2025-03-28","current":-17.581737,"twenty":-28.470275,"median":-24.772663,"eighty":-20.685126,"marketCap":711269162},{"date":"2025-04-04","current":-16.606451,"twenty":-28.455071,"median":-23.826348,"eighty":-20.087337,"marketCap":671813989},{"date":"2025-04-11","current":-9.885848,"twenty":-28.423651,"median":-23.117849,"eighty":-19.576639,"marketCap":399931979},{"date":"2025-04-17","current":-12.847169,"twenty":-28.370492,"median":-23.028668,"eighty":-18.81521,"marketCap":519732232}],"updateTime":1745022646183}}}